The global Interventional Cardiology Devices market size is projected to reach USD 22 billion by 2026 at a CAGR of 9.1% from USD 14.2 billion in 2021 during the forecast period 2021-2028.
Interventional devices or MID use catheter-based technology are the devices primarily used for the treatment of the structural heart disease. These are of various different kinds and are deployed to use on the basis of type of the heart blockage.
With the increased incidents of CAD or coronary artery disease along with increased tobacco consumption and the availability of alternative treatment are some of the factors that have supported long-term expansion for Interventional Cardiology Devices Market.
The COVID-19 pandemic is causing widespread concern and economic hardship for consumers, businesses, and communities across the globe. The sales have been impacted dure to the nationwide lockdown across the globe along with the social distancing norms leading to a decline in the market.
North America is expected to be the largest market during the forecast period. Increased cases of diabetes along with the rise in the aging population has led to the expansion of the market in the region.
Insights are provided for each region and major countries within the regions
|
Report Feature |
Descriptions |
|---|---|
|
Market Revenue In 2021 |
USD 14.2 billion |
|
Growth Rate |
CAGR of 9.1% during the forecasting period, 2021-2028 |
|
Historical Data |
2018-2019 |
|
Forecast Years |
2021-2028 |
|
Base Year |
2020 |
|
Units Considered |
Revenue in USD million and CAGR from 2021 to 2028 |
|
Report Segmentation |
Product and geography |
|
Report Attribute |
Market Revenue Sizing (Global, Regional and Country Level) Company Share Analysis, Market Dynamics, Company Profiling |
|
Regional Level Scope |
North America, Europe, Asia-Pacific, South America, and Middle East and Africa |
|
Country Level Scope |
U.S., Japan, Germany, U.K., China, India, Brazil, UAE, South Africa (50+ Countries Across the Globe) |
|
Companies Profiled |
Medtronic , Boston Scientific Corporation . Abbott . Edward Lifescinces Corporation , Cardinal Health . iVascular (Spain), B. Braun Melsungen , Terumo Corporation , Biosensors International Group , and BIOTRONIK SE & Co. KG |
|
Available Customization |
In addition to the market data for Interventional Cardiology Devices Market, Delvens offers client-centric report and customized according to the company’s specific demand and requirement. |
Interventional Cardiology Devices Market is segmented into Product and geography.
.png)
.png)
.png)
.png)
.png)
.png)